Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 9/2018

01-09-2018 | Breast Oncology

Why Do Reoperation Rates Vary So Much After Lumpectomy for Breast Cancer? Examining the Reoperation Puzzle at the Massachusetts General Hospital

Published in: Annals of Surgical Oncology | Issue 9/2018

Login to get access

Excerpt

Focusing on reoperations after initial lumpectomy for breast cancer, Valero and colleagues report the end results of the Massachusetts General Hospital (MGH) experience in this issue of the Annals of Surgical Oncology. Reoperations occurred for 114 (22.9%) of 490 patients with stage 1 or 2 breast cancer undergoing lumpectomy at MGH in 2014. The unadjusted reoperation rates among eight surgeons ranged from 16 to 40%. After multivariate risk adjustment, significant differences by individual surgeon persisted. …
Literature
1.
1. McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307:467–75.CrossRefPubMed
2.
2. Wilke LG, Czechura T, Wang C, et al. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004–2010. JAMA Surg. 2014;149:1296–305.CrossRefPubMed
3.
3. Jeevan R, Cromwell DA, Trivella M, et al. Reoperation rates after breast-conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ. 2012;345:e4505.CrossRefPubMedPubMedCentral
4.
van Leeuwen MT, Falster MO, Vajdic CM, et al. Reoperation after breast-conserving surgery for cancer in Australia: statewide cohort study of linked hospital data. BMJ Open. 2018;8:e020858-2017-020858.
5.
5. Isaacs AJ, Gemignani ML, Pusic A, Sedrakyan A. Association of breast conservation surgery for cancer with 90-day reoperation rates in New York State. JAMA Surg. 2016;151:648–55.CrossRefPubMed
6.
6. Ong WL, Schouwenburg MG, van Bommel ACM, et al. A standard set of value-based patient-centered outcomes for breast cancer: the International Consortium for Health Outcomes Measurement (ICHOM) initiative. JAMA Oncol. 2017;3:677–85.CrossRefPubMed
7.
7. Landercasper J, Bennie B, Parsons BM, et al. Fewer reoperations after lumpectomy for breast cancer with neoadjuvant rather than adjuvant chemotherapy: a report from the National Cancer Database. Ann Surg Oncol. 2017;24:1507–15.CrossRefPubMedPubMedCentral
8.
8. Houssami N, Macaskill P, Marinovich ML, Morrow M. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2014;21:717–30.CrossRefPubMedPubMedCentral
9.
9. Marinovich ML, Azizi L, Macaskill P, et al. The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2016;23:3811–21.CrossRefPubMedPubMedCentral
10.
10. Chagpar AB, Killelea BK, Tsangaris TN, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med. 2015;373:503–10.CrossRefPubMedPubMedCentral
11.
11. Landercasper J, Attai D, Atisha D, et al. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American Society of Breast Surgeons Consensus Conference. Ann Surg Oncol. 2015;22:3174–83.CrossRefPubMedPubMedCentral
12.
12. Del Turco MR, Ponti A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer. 2010;46:2344–56.CrossRefPubMed
13.
13. Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer. Ann Surg Oncol. 2014;21:704–16.CrossRefPubMed
14.
14. Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ. Ann Surg Oncol. 2016;23:3801–10.CrossRefPubMedPubMedCentral
15.
15. Landercasper J, Whitacre E, Degnim AC, Al-Hamadani M. Reasons for reexcision after lumpectomy for breast cancer: insight from the American Society of Breast Surgeons Mastery(SM) Database. Ann Surg Oncol. 2014;21:3185–91.CrossRefPubMed
16.
16. Guidi AJ, Tworek JA, Mais DD, Souers RJ, Blond BJ, Brown RW. Breast specimen processing and reporting with an emphasis on margin evaluation: a College of American Pathologists survey of 866 laboratories. Arch Pathol Lab Med. 2018;142:496–506.CrossRefPubMed
17.
17. Birkmeyer JD, Finks JF, O’Reilly A, et al. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013;369:1434–42.CrossRefPubMed
18.
Metadata
Title
Why Do Reoperation Rates Vary So Much After Lumpectomy for Breast Cancer? Examining the Reoperation Puzzle at the Massachusetts General Hospital
Publication date
01-09-2018
Published in
Annals of Surgical Oncology / Issue 9/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6609-0

Other articles of this Issue 9/2018

Annals of Surgical Oncology 9/2018 Go to the issue

Gastrointestinal Oncology

Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing

Hepatobiliary Tumors

Long-Term Oncologic Outcomes Following Robotic Liver Resections for Primary Hepatobiliary Malignancies: A Multicenter Study

Endocrine Tumors

Impact of Extent of Surgery on Tumor Recurrence and Survival for Papillary Thyroid Cancer Patients

Breast Oncology

The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy

Gastrointestinal Oncology

Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden

Gastrointestinal Oncology

Young Age and Risk of Lymph Node Metastasis in Differentiated Type Early Gastric Cancer